Harrison-Gómez C, Harrison-Ragle D, Sánchez-Lezama F, Arceo-Navarro A, Arredondo-Arzola VM, Domínguez-Carrillo LG

Language: Spanish
References: 10
Page: 173-175
PDF size: 123.24 Kb.

ABSTRACT

Familial hypocalciuric hypercalcemia is a genetic disorder of mineral metabolism, characterized by moderate hypercalcemia throughout lifelong with normo or hypocalciuric and there can be a discrete increase in parathyroid hormone. Case report: male aged 23, three weeks of evolution with headache, nausea, blurred vision, fatigue, insomnia and constipation. Normal physical examination except for blood pressure 170/100. With serum calcium of 11.5 mg/dl; low levels of 25-hydroxyvitamin D; scan with Technetium mibi of parathyroid and ultrasound scan / normal renal Doppler; relationship of debugging calcium/creatinine of 0.005 and urinary excretion of calcium of 98 mg/24 hours. The diagnosis was familial hypercalcemia hypocalciuric. Conclusion: high blood pressure can be caused by hypercalcemia; control of serum calcium concentration can improve blood pressure control and prevent damage to target organs.

REFERENCES

1. Shinall MC, Dahir KM, Broome JT. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism. Endocr Pract. 2013;19:697-702.

2. Karthikeyan VJ, Khan JM, Lip GY. Hypercalcemia and the cardiovascular system. Heart Metab. 2006;30:25-9.

3. Stratta P, Merlotti G, Musetti C, Quaglia M, et al. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population. Nephrol Dial Transplant. 2014;29:1902-9.

4. Tenhola S, Hendy GN, Valta H, Canaff L, Lee BS, Wong BY, et al. Cinacalcet Treatment in an Adolescent With Concurrent 22q11.2 Deletion Syndrome and Familial Hypocalciuric Hypercalcemia Type 3 Caused by AP2S1 Mutation. J Clin Endocrinol Metab. 2015;100:2515-8.

5. Jong WK, Kwang PK, Hee JK, Tounjhin A, et al. Plasma calcium and risk of hypertension: Propensity score analysis, using data from the Korean genome and epidemiology study. Osong Public Health Res Perspect. 2011;2:83-8.

6. Marone C, Beretta PC, Weidmann P. Acute hypercalcemic hypertension in man: role of hemodynamics, catecholamines, and rennin. Kidney International. 1981;20:92-6.

7. Eiam OS, Punsin P, Sitprija V, Chaiyabutr N. Acute hypercalcemia-induced hypertension: the roles of calcium channel and alpha-1 adrenergic receptor. J Med Assoc Thai. 2004;87:410-8.

8. Tordjman KM, Yaron M, Izkhakov E, Osher E, et al. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. European Journal of Endocrinology. 2010;162:925- 33.

9. Ahlstrom T, Hagstrom E, Larsson A. Correlation between plasma calcium, parathyroid hormone and the metabolic syndrome in a communitybased cohort of men and women. Clin Endocrinol. 2009;71:673-8.

10. Li YC, Kong M, Chen ZF, Liu SQ, et al. 1,25-Dihydroxyvitamin D (3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229-38.